newsfilter
← Latest News
PR Newswire·

Cellect Biotechnology Reports Third Quarter 2019 Financial and Operating Results

Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today reported...